Bmr. Quinto et al., Characterization of a kinin inactivating serine endopeptidase H2 (kininase) from human urine using fluorogenic substrates, IMMUNOPHARM, 45(1-3), 1999, pp. 223-228
We have previously described a kinin-inactivating endopeptidase (H2), which
was purified 19-fold from human urine by DEAE-cellulose chromatography and
gel filtration. The enzyme was inhibited 100% by PMSF, TPCK and pOHMB. In
the present communication, we further characterized this enzyme using the f
luorogenic substrates Abz-RPPGFSPFRQ-EDDnp (Abz-BKQ-EDDnp) and Abz-FRQ-EDDn
p (Abz = ortho-aminobenzoic acid; EDDnp = N-[2,4-dinitrophenyl] ethylenedia
mine). Also a rapid, sensitive and specific assay for the H2 was developed.
The enzyme hydrolyzed bradykinin (BK = RPPGFSPFR) at the F-S peptide bond,
differing from the cleavage site F-R, in the fluorogenic substrates Abz-BK
Q-EDDnp and Abz-FRQ-EDDnp. Other enzymes present. in urine als the serine e
ndopeptidase III, prolyl endopeptidase and neutral endopeptidase-like were
not able to hydrolyze the related substrate Abz-FRQ-EDDnp. The determined K
-m for Abz-BKQ-EDDnp and Abz-FRQ-EDDnp were 0.79 mu M and 3.02 mu M, respec
tively. Using the fluorogenic substrates, we observed that PMSF and p-hydro
xymercuribenzoate irreversibly inhibited the enzyme H2. E-64 was a weak and
reversible inhibitor, whereas EDTA and pepstatin were not inhibitory. The
inhibition observed in the presence of pOHMB was partially reversed by 2 mM
cysteine. These results suggest that the H2 enzyme belongs to the subfamil
y of SH-containing serine proteases. Based on the molecular weight of isola
ted H2 (60 kDa), we believe that this enzyme originated from the kidney and
may cleave the kinins filtered through the glomerulus and also that produc
ed in the kidney. (C) 1999 Published by Elsevier Science B.V. All rights re
served.